Nichols: Lung Cancers Flashcards
In general, lung cancers are more common and fatal in what sex/race? less common less fatal?
black males > asians and hispanics
3 major types of lung cancer
adenocarcinoma
squamous cell
small cell
assc with inapproprate ADH expression
small cell
–> leads to hyponatremia
more commonly peripherial
adenocarinomas
assc with Easton-Lambert syndrome
small cell
*due to autoantibodies against P/Q type voltage-gated calcium channels
commonly causes hypercalcemia
squamous cell carcinomas
**due to the production of a substance resembling parathyroid hormone
commonly metastatic at presentation
small cell
causes post-obstructive pneumonia
squamous cell carcinoma
more commonly central
small cell
commonly causes cavitation
squamous cell
assc with cushing syndrome
small cell
more common in women, asians, and never smokers
adenocarcinomas
common symptoms assc with lung cancer
cough (60%) > dyspnea > weight loss, hemoptysis > chest pain > horeseness (10%)
common signs assc with lung cancer
none
How is lung cancer Dx?
- discover via radiology (screen 55-80 y/o with 30+ pack-years Hx)
- biopsy
What type of lung cancer is tx with sugery
early stage squamous and adenocarcinoma (aka non-small cell)
treatment for non-small cell carcinoma
early stages: surgery
later stages: chemo (carboplatin + docataxel)
drug target for mutated ALK
crizotinib
WHat is the prognosis of lung caner as a whole?
5 year survival of 17%
malignant epithelial tumor of lung with glandular features such as making glands or mucin
adenocarcinoma (lung primary adenocarcinoma)
70% of never smokers with lung cancer have
adenocarcinoma
role of filtered cigarettes in the increased of adenocarcinoma
filter removed large particles = increased particle deposition in small airways
other causes of adenocarcinoma other than cigarette smoke
radon gas from ground
radiation
asbestos
Mutation common in adenocarcinomas of never smokers
EGFR
Mutation common in adenocarcinomas of smokers
KRAS
KRAS mutation confers resistance to what drug?
erlotinib
EGFR mutations confers responsiveness to what drug?
gefitinib and erlotinib
crizotinib effectiveness requires what mutation?
EML4-ALK translocation fusion oncogene
*it is an ALK inhibitor
What mutations are seen in adenocarcinoms?
EFGR KRAS EML4-ALK p53 c-MET NKX2-1 PIK3CA BRAF
Tx for inoperable adenocarcinomas
pemetrexed
antifolate metabolite inhibitor of thymidylate synthetase, inhibiting the formation of precursor purine and pyrimidine nucleotides, preventing the formation of DNA and RNA
pemetrexed
anti-vascular endothelial growth factor (VEGF) monoclonal antibody
bevacizumab
What microscopic pathologies of adenocarcinoma are assc with a good prognosis?
bad?
good: lepidic (without invasion) = spreading within alveoli
bad: micopapillary, solid
Tx options for adenocarcinomas
erlotinib, pemetrexed, bevacizumab
prognosis for adenocarcinomas
determined by stage:
early stage live about 20 months on average
late stage about 13 months
**no KRAS = + 5 mos
**EML4-ALK translocation fusion oncogene + 5 mos
Describe the common pathology of adenocarcinomas
peripheral, subpleural, solitary, lobulated or spiculated
non-invasive neoplasm characterized by non-destructive growth along intact alveolar septa
adenocarcinoma in situ
involves type II pneumocytes and Clara cells
non-mucinous adenocarcinoma in situ
metaplasia of bronchilar epithelium
municnous adenocarcinoma in situ
can become mulitfocal from tumor spread via airways and the mucocilliary escalator
municnous adenocarcinoma in situ
CK20 negative and TTF-1 positive
non-mucinous adenocarcinoma in situ